Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin and Food Intake in African Americans
NCT04739371Phase 1Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of regular human insulin in Alzheimer's disease (AD) (2 arms), sponsored by Pennington Biomedical Research Center. Primary endpoints: Change in caloric intake and Change in ingestive behavior constructs. Started Jun 2021; status: completed.
02
Drugs
regular human insulin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04739371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739371.